Use of Biologics in IgE mediated diseases A case based discussion on Omalizumab

Speciality: Emergency Medicine


Speaker:

Dr Deepak Talwar - Moderator |

Dr. Arun C Kotaru - Panelist |

Dr Aditya Chawla - Panelist |

Dr Pooja Agarwal - Panelist |

Dr Vinay Singh - Panelist |

Description:

 A warm welcome to all the medical professionals in this interesting session on Use of Biologics in IgE mediated diseases A case based discussion on Omalizumab
The use of biologics in treating IgE-mediated diseases has revolutionized the management of conditions like asthma, chronic idiopathic urticaria, and allergic rhinitis. These therapies target specific pathways involved in the allergic response, offering more precise and effective treatment options compared to traditional therapies. Omalizumab, an anti-IgE monoclonal antibody, is a prominent biologic used in these cases.
Omalizumab works by binding to free IgE antibodies in the blood, preventing them from attaching to IgE receptors on mast cells and basophils. This action inhibits the release of inflammatory mediators that cause allergic symptoms. By directly targeting the IgE pathway, omalizumab reduces the frequency and severity of allergic reactions, offering significant relief for patients with severe allergic conditions.
In a case-based discussion, a patient with severe allergic asthma who has not responded to standard treatments can illustrate the effectiveness of omalizumab. After initiating omalizumab therapy, the patient experiences a marked reduction in asthma exacerbations and improved lung function. 
Therefore, get an overall knowledge of use of biologics in IgE mediated diseases A case based discussion on Omalizumab
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Patients face high out-of-pocket costs after incident cancer diagnosis

2.

In a study, immune detection of oral cancers is linked to obesity.

3.

Researchers found that patients undergoing chemotherapy had a higher risk of mixed infections and should begin antibiotic therapy right away.

4.

Every cancer is different because of how evolution causes drug resistance and why various cancers require various treatments.

5.

Common intracellular toxin could help fight leukemia


© Copyright 2025 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot